Pharmacokinetics and Pharmacodynamics of Ertapenem in Patients With Tuberculosis

Trial Profile

Pharmacokinetics and Pharmacodynamics of Ertapenem in Patients With Tuberculosis

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Aug 2017

At a glance

  • Drugs Ertapenem (Primary)
  • Indications Tuberculosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 24 Aug 2017 Status changed from recruiting to completed.
    • 15 Dec 2016 Status changed from not yet recruiting to recruiting.
    • 01 Sep 2016 Planned End Date changed from 1 Jun 2016 to 1 Nov 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top